Latest News - Phase 3/4 Trials

Thursday, January 05, 2017 | Dementia & Cognitive Disorders, Phase 3/4 Trials, Research and Publications

Neuronix Reveals Data Suggesting Non-invasive TMS Device Improves Cognitive Performance in Alzheimer’s Disease

New findings suggest that an investigational device that combines transcranial magnetic stimulation (TMS) with cognitive training may improve cognitive performance in individuals with Alzheimer&r…

Read the full story

Thursday, November 17, 2016 | Pain & Headache, Phase 3/4 Trials, Phase 3/4 Trials, Research and Publications

Investigational Biologic for the Treatment of Migraine Shows Promise in Phase 3 Data

New Phase 3 trial results suggest that Amgen’s investigational biologic agent erenumab may be effective at reducing migraines. Erenumab was specifically designed to prevent migraine by bloc…

Read the full story